Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

23 Mar 2020 07:00

RNS Number : 1202H
Electrocomponents PLC
23 March 2020
 

Electrocomponents plc today issues a pre-close trading update for the year ending 31 March 2020 and an update on COVID-19, ahead of reporting full-year results in May 2020.

COVID-19 update

As we closely monitor the impact of COVID-19, our priority is to safeguard the health and wellbeing of our employees and to continue to support our customers and suppliers across the globe. As we do so, we are adhering to advice from government health agencies including the World Health Organisation.

In January we formed a central crisis management team to manage our response to the outbreak in Asia Pacific and our experience there has meant that we have been able to quickly implement business continuity plans across the globe. These plans include:

· Monitoring inventory and our supply chain to ensure consistency of supply,

· Building continuity plans for our distribution centres, and

· Extensive home working for our office-based teams.

These plans are working well and the response of our people has been outstanding. At the present time, all our distribution centres around the world remain open and operating effectively, with the exception of our distribution centres in France and Italy. We are currently servicing our French and Italian customers out of the UK. Our online business model continues to differentiate us and has helped us maintain service levels to our customers which include critical industries such as the public sector, food and beverage, power generation and utilities. However, whilst we continue to be able to manage the supply side, there is now evidence that increasing restrictions in some of our major markets are impacting demand. 

Current trading

Up to and including the week ended 15 March 2020, the Group saw limited impact from COVID-19 on levels of customer demand.

· Group like-for-like(1) revenue growth in the 11-week period ended 15 March was c. 4%.

· All three regions saw positive like-for-like revenue growth across the period, with EMEA up 3%, Americas up 3% and Asia Pacific strongly up 11%.

While market conditions are changing rapidly and it is difficult to draw conclusions from a single week of trading, it is notable that in the week ended 22 March like-for-like Group revenue growth has slowed to a high single-digit decline. Revenue trends have worsened across the week and volume levels vary considerably between markets. Those markets where public mobility has been most restricted, such as Italy and France, are seeing the largest impact with volumes down significantly driven primarily by lower demand. Other markets, where restrictions are only just now being implemented, such as the UK and US, are seeing a more modest impact on revenue at this stage.

While we currently expect to deliver adjusted(2) PBT for the year ending 31 March 2020 around the bottom end of our current market consensus(3) range, it remains a rapidly evolving situation. It remains too early to assess the impact that the unfolding COVID-19 situation will have on trading in the year ending 31 March 2021.

Balance sheet and liquidity

We enter this period of uncertainty in a strong financial position with a cash generative business model.

· At 30 September 2019 net debt to adjusted EBITDA was 0.9 times and adjusted EBITA to interest was over 40 times.

· Our financial covenants are net debt to adjusted EBITDA < 3.25 times and adjusted EBITA to interest of > 3 times.

· Net debt on 29 February 2020 was £209 million (including £57 million of lease liabilities), down from £221 million at 30 September 2019.

· Current committed facilities amount to £380 million, with over £340 million of these facilities maturing beyond July 2022. As of 29 February 2020, c.£180 million of our facilities are undrawn.

Mitigating actions

In anticipation of lower demand levels in the short term we are acting now to protect profitability and to conserve cash, while seeking to ensure the Group is well placed to benefit when the recovery takes place. We are reviewing all discretionary expenditure, both operating and capital, and considering suitable government assistance programmes in the markets in which we operate to preserve the productive capacity of the business as far as possible.

We will continue to support the needs of all our customers, suppliers and employees through this challenging period. Electrocomponents is also assisting the fight against COVID-19 by supporting one of the UK manufacturing consortia as they seek to rapidly develop new medical ventilation equipment.

Overall

The Group's strong financial position, coupled with our differentiated online business model, global distribution network and strong supplier relationships, means that we remain well positioned to weather the present crisis and to continue driving growth and market share gains over the medium term.

LEI: 549300KVXDURRKVWR37

 

Enquiries:

David Egan

Chief Financial Officer

020 7239 8400

Polly Elvin

Head of Investor Relations

020 7239 8427

Martin Robinson/ Lisa Jarrett-Kerr

Tulchan Communications

020 7353 4200

 

Notes:

1. Like-for-like revenue growth is growth in revenue adjusted to eliminate the impact of acquisitions, changes in exchange rates and trading days year on year. Acquisitions are only included once they have been owned for a year, at which point they start to be included in both the current and comparative periods for the same number of months. 2019 is converted at 2020 average exchange rates for the period.  

2. Adjusted excludes amortisation of intangible assets arising on acquisition of businesses, substantial reorganisation costs, substantial asset write-downs, one-off pension credits or costs, significant tax rate changes and associated income tax.

3. The current consensus range for adjusted PBT for the year ending 31 March 2020 is £209.2 million to £216.0 million.

4. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. Average exchange rates for the year ended 31 March 2019 for euro and US$ respectively were €1.13 and $1.31 respectively. Every 1 cent movement in the euro has a circa £1.4 million impact on annual profit. Every 1 cent movement in the US $ has a circa £0.5 million impact on annual profit.  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFFFSIVSIFFII
Date   Source Headline
3rd May 20224:15 pmRNSChange of Name
3rd May 20229:00 amRNSTotal Voting Rights
21st Apr 202210:00 amRNSHolding(s) in Company
12th Apr 20227:00 amRNSTrading Statement
1st Apr 20229:45 amRNSTotal Voting Rights
31st Mar 20223:30 pmRNSCompany Secretary Change
30th Mar 20227:00 amRNSInvestor Event 2022: Our Journey to Greatness
28th Mar 202212:10 pmRNSDirectorate Change
28th Mar 202210:00 amRNSAdditional Listing
9th Mar 20223:00 pmRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSTrading Statement
1st Mar 20223:00 pmRNSTotal Voting Rights
25th Feb 20223:00 pmRNSHolding(s) in Company
15th Feb 20225:30 pmRNSHolding(s) in Company
8th Feb 20223:46 pmRNSNotice of Investor Event and Trading Update
1st Feb 20225:10 pmRNSHolding(s) in Company
1st Feb 20222:00 pmRNSTotal Voting Rights
1st Feb 20221:49 pmRNSBlock listing Interim Review
31st Jan 20225:30 pmRNSHolding(s) in Company
27th Jan 20225:50 pmRNSHolding(s) in Company
11th Jan 20223:30 pmRNSDirector/PDMR Shareholding
11th Jan 20227:00 amRNSTrading Statement
10th Jan 20224:00 pmRNSHolding(s) in Company
4th Jan 202211:04 amRNSTotal Voting Rights
17th Dec 20215:00 pmRNSHolding(s) in Company
17th Dec 20212:00 pmRNSNotice of Trading Update
10th Dec 202111:00 amRNSCompany Secretary Change
9th Dec 20219:37 amRNSHolding(s) in Company
7th Dec 202110:25 amRNSHolding(s) in Company
1st Dec 202110:21 amRNSTotal Voting Rights
11th Nov 20213:01 pmRNSHolding(s) in Company
10th Nov 20213:50 pmRNSHolding(s) in Company
4th Nov 20217:01 amRNSGlobal 2030 ESG Action Plan: For A Better World
4th Nov 20217:00 amRNSHalf-year Report
1st Nov 202110:00 amRNSTotal Voting Rights
8th Oct 20217:00 amRNSTrading Statement
1st Oct 202110:00 amRNSTotal Voting Rights
20th Sep 20211:00 pmRNSNotice of Trading Update
13th Sep 20213:00 pmRNSDirector/PDMR Shareholding
9th Sep 202112:00 pmRNSDirector/PDMR Shareholding
1st Sep 20219:59 amRNSTotal Voting Rights
3rd Aug 202110:07 amRNSTotal Voting Rights
3rd Aug 202110:05 amRNSBlock listing Interim Review
27th Jul 20216:18 pmRNSDirector/PDMR Shareholding
26th Jul 20216:06 pmRNSHolding(s) in Company
16th Jul 20213:00 pmRNSHolding(s) in Company
15th Jul 20213:00 pmRNSResult of AGM
8th Jul 20217:00 amRNSTrading Statement
7th Jul 20214:00 pmRNSDirectorate Change
1st Jul 202111:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.